| 查看: 939 | 回复: 5 | |||
liufawen荣誉版主 (文学泰斗)
发哥早已不在江湖...
|
[交流]
【Pure water】Chinese medicine increasingly recognized in US
|
|
Traditional Chinese medicine (TCM) has gained legal and consumer recognition in the United States in the last 30 years, but achieving its current status was no simple task. "Back in the 1970s, TCM had no legal status, and most Western doctors were hostile to non-conventional medical practice," John Scott, president of Golden Flower Chinese Herbs, said. When Scott and his wife, Lorena Monda, founded Golden Flower Chinese Herbs in 1990 to produce and distribute Chinese herbal formulae, Chinese herbs were already quite popular, especially in the Chinatowns of big American cities like San Francisco and New York City. However, in those days, Chinese medicine was not a legal entity. Mark Blumenthal, founder and executive director of American Botanical Council, said though California was the first state to legalize acupuncture in 1978, Chinese herbal medicine continued to remain in the "twilight zone" until the US Congress passed the Dietary Supplement Health and Education Act (DSHEA) in 1994. According to its website, the US Food and Drug Administration (FDA) defines a "dietary supplement" as a product taken by mouth that contains a 'dietary ingredient' intended to supplement the diet which includes vitamins, minerals and herbs or other botanicals. "After 1994, with Chinese herbal medicine declared a 'dietary supplement,' you can't legally say you are treating diseases. This is difficult for us because TCM is an old practice for treating illnesses and diseases. Our method of perceiving diseases is considered different from modern medicine," Scott said. But there has been a growing demand for acupuncture in the US – a practice now legalized in 44 states, as compared to just four states 30 years ago. Insurance companies pose another major threat to the legitimacy of the practice, making a distinction between acupuncture treatments and Chinese herbal treatments. A patient can make an insurance claim for acupuncture but not for herbal treatment. "Insurance companies won't pay for treatment of diseases with herbal medicine. Acupuncture coverage depends on the insurance policy and its restrictions, as well as the conditions of the patient," Scott said. But there is a ray of hope for herbal medicine to be legitimized for treatment of illnesses and diseases. In July, the Compound Danshen Dripping Pill, a Chinese herbal treatment for angina and coronary heart disease, successfully completed the FDA's Phase II clinical trials. Once it passes Phase III investigations, which would most likely happen in 2013, it would be the first-ever Chinese medicine to become a prescription drug in the US. Blumenthal said that this would be an FDA endorsement of the herbal combination to treat potentially serious illnesses. "There is no government approval of 'herbal supplements' to treat cancers. But in this case, you have a government review of what is being sold by an acupuncturist or at the health food stores. This will be the first time the government approved of Chinese medicine as drug use," he said. While it is generally believed that the FDA-approved Danshen could pave the way for an increased acceptance and use of Chinese medicine by certain members of the medical profession, some TCM practitioners think it will mean "losing access". Bill Reddy, an acupuncturist based in Annadale, Virginia, thinks that Chinese herbal medicine should be prescribed by a properly trained herbal practitioner. "We do not diagnose illnesses and diseases the same way as Western medicine, and do not prescribe our herbs with the 'one size fits all' mentality that dominates Western medicine," Reddy said. Blumenthal said that if Danshen is standardized as a prescription drug, it is possible that it would be prepared in a different formula from those sold by acupuncturists. Due to the chemical complexity of Chinese herbs, Blumenthal thinks it would be very challenging to make herbs into a pharmaceutical drug which contains one or two molecules, but, he said, "You will have a reliable and standardized medicine." "This does not mean that those sold by acupuncturists will not be as good. Depending on its use, those traditionally made may be better for some illnesses. However, there is no clinical proof of that." Though difficult, it is not impossible for Chinese herbs to pass the FDA's drug approval process, he added. Blumenthal thinks that if Danshen is approved as a drug, in the long run, it will help legitimize TCM in the eyes of the Western communities and even stimulate more investments in Chinese medicine. It costs a reported $800 million to $1.3 billion to conduct the research and development needed to bring a new drug to the market, according to an article on HerbalGram magazine issued by the American Botanical Council. There is currently no available data showing how many companies are in line to make applications for Chinese medicine to be approved for drug use. A staff member at the FDA Office of Public Affairs said they are unable to comment on drugs under development or even confirm they are the subject of clinical trials. According to Blumenthal, there have been only two drug approvals for Chinese medicine in the last 50 years. In 2006, the FDA gave drug approval to Veregen® Ointment, which contains Chinese green tea leaves, to treat genital warts caused by human papillomavirus in the US. Danshen could be the first multi-chemical plant approved for drug use, said Blumenthal. |
回复此楼» 猜你喜欢
河北省自然科学基金
已经有8人回复
-
西安交大新媒学院副院长用撤稿论文结题
已经有5人回复
-
论文撤稿了
已经有5人回复
-
某211大学教师把个人教师官方主页改成:我跑了我跑了我跑了!官宣跑路！
已经有5人回复
-
26/27申博自荐
已经有9人回复
-
售SCI一区T0P文章，我:8.O.5.5.1.O.5.4,科目齐全,可+急
已经有3人回复
-
售SCI一区T0P文章，我:8.O.5.5.1.O.5.4,科目齐全,可+急
已经有7人回复
-
揭秘青基评审内幕：几个A才能顺利中标
已经有4人回复
-
青B发送上会通知了吗
已经有7人回复
-
博士申请
已经有3人回复
★
小木虫(沙发+1，金币+0.5):恭喜抢个沙发，再给个红包
小木虫(沙发+1，金币+0.5):恭喜抢个沙发，再给个红包
 |
2楼2010-12-05 14:40:42
★
小木虫(金币+0.2):抢了个小板凳，给个红包
小木虫(金币+0.2):抢了个小板凳，给个红包
 |
3楼2010-12-05 14:56:21
m0626
木虫 (著名写手)
- 应助: 1 (幼儿园)
- 金币: 3451.5
- 散金: 12
- 红花: 4
- 帖子: 1933
- 在线: 521.4小时
- 虫号: 1087711
- 注册: 2010-09-02
- 性别: GG
- 专业: 凝聚态物性 II ：电子结构
4楼2010-12-05 21:37:11
 |
5楼2010-12-05 22:17:42
sgh_119
至尊木虫 (职业作家)
- ESEPI: 1
- 应助: 0 (幼儿园)
- 贵宾: 0.045
- 金币: 15120.1
- 红花: 13
- 沙发: 59
- 帖子: 4989
- 在线: 648.4小时
- 虫号: 614182
- 注册: 2008-09-27
- 性别: GG
- 专业: 绿色有机化学
6楼2010-12-05 22:54:44
10